Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 454 results for "cipla"

Adil Zainulbhai joins Cipla as Independent Director

Details Category: Latest Updates Published on Friday, 25 July 2014 14:00 He was the Chairman of McKinsey India Cipla has appointed Adil Zainulbhai as an independent director on the Board. Zainulbhai retired as Chairman of McKinsey ... Express Pharma, 5 hours ago
Cipla appoints independent director Hindu Business Line, 7 hours ago
Board of Cipla appoints director HDFC Securities, 1 day ago

205 images for cipla

International Business Times India, 1 week ago, 1 week ago
IBN Live, 1 week ago, 1 week ago
Bio Spectrum Asia, 1 week ago
DNA, 4 days ago
Business Today India, 2 weeks ago
Pharma Letter, 6 days ago
Hindu Business Line, 2 weeks ago
IBN Live, 1 week ago

McKinsey India ex-Chairman in Cipla board

Posted on July 25, 2014 by subhashd in Corporate Updates, Development, Featured, India, News, Pharma Cipla, a global pharmaceutical company is delighted to announce the appointment of Mr Adil Zainulbhai as an independent director on the Board. ...
 EHealth Magazine43 minutes ago Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines  Research and Markets1 week ago Sun Pharma, Dr Reddy's rally on strong gross sales in June  Money Control2 weeks ago India Pharmaceutical Market 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMs), Biosimilars, Generics & Vaccines  Individual.com4 days ago

Cipla Buys Out Biotech Firm MabPharm

@Cipla_Limited1 Limited, through its wholly owned subsidiary @Meditab Private Limited has hiked its stake to 100% in Goa based biotech firm Mabpharm Private Limited for an undisclosed amount. Cipla previously held 25% stake in the company and with ...
 Deal Curry4 days ago Cipla : buys Goa-based biotech firm  4 Traders6 days ago Cipla acquires balance 75% stake in biotech firm Mabpharm  VC Circle1 week ago Cipla buys remaining 75% stake in Mabpharm  DNA1 week ago

Cipla sprints up nearly 2% on BSE

Cipla was the top gainer in morning trade on the BSE on Thursday. At 11.10 am the pharma stock held gains of 1.89 per cent to trade at ₹439.95. The stock had closed the previous session at ₹431.80. IT stocks Infosys and Wipro also made gains ...
 Hindu Business Line1 week ago Cipla up nearly 2% on BSE  Business Line1 month ago Cipla holds on to morning gains, up 3.3% on BSE  Business Line1 month ago Cipla perks up over 3% on BSE  Business Line1 month ago
Business Standard

Cipla, Mylan, Micro Labs, Aurobindo, Emcure ink licensing pact for antiretrovirals with a UN unit

Medicines Patent Pool has signed seven new sub-licences for generic HIV medicines with Cipla, Mylan, Micro Labs, Aurobindo, Laurus Labs, Emcure and Desano (a Chinese manufacturer) BS B2B Bureau | Mumbai July 17, 2014 Last Updated at 16:48 IST Medicines Patent ...
 Business Standard1 week ago MPP announces 7 new sub-licensing agreements for manufacture of generic HIV medicines  News-Medical.Net1 week ago The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries  Red Orbit6 days ago MPP signs seven sub-licensing agreements to manufacture HIV medicines  Express Pharma1 week ago

Cipla, Aurobindo in Medicines Patent Pool agreement on anti-AIDs drugs

With just three days to go for the 20th International AIDS conference in Melbourne, the United Nations-backed Medicines Patent Pool (MPP) has announced an agreement with seven drugmakers for the manufacture of two anti-AIDS medicines. And ...
 Hindu Business Line1 week ago Medicines Patent Pool inks pact with 7 firms for anti-AIDS drugs  The Hindu1 week ago

Cipla, Aurobindo, Emcure to supply HIV drugs for UN-backed MPP

Related to : Cipla Ltd Cipla Ltd BSE 17 Jul 14 | 12:00 AM 437.15 5.35 (1.24%) NSE 17 Jul 14 | 12:00 AM 437.05 4.9 (1.13%) Three Indian pharmaceutical firms, Cipla, Aurobindo and Emcure, are among seven global companies that have ...
 Smart Investor1 week ago Cipla, Aurobindo,Emcure to supply HIV drugs for UN-backed prog  Business Standard1 week ago

Cipla acquires monoclonal antibodies maker Mabpharm

Mabpharm, a manufacturer of monoclonal antibodies for treatment of cancer and auto-immune diseases, will now become a wholly-owned subsidiary of Cipla
 Business Standard1 week ago

Cipla becomes sublicensing partner of the Medicines Patent Pool

This page uses frames, but your browser doesn't
 Capital Market1 week ago
IBN Live

Make essential drugs affordable for all: Cipla

Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly". "As a ...
 IBN Live1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less